Our Goals:
HomeoPet®’s aim is to provide leading edge research for the development of effective and novel treatments which are both homeopathic by definition and still meet the full criteria of evidence based medicines.
Why We Research:
HomeoPet® research is primarily targeted at improving the quality of life for animals in general. All of HomeoPet®’s trials provide data which expands the general knowledge of the conditions on which our research is being conducted. We’re committed to publishing both positive and negative data so that others do not have to futilely traverse the same ground in the future, as we learn both by our success and our failures equally.
Our Standards of Research:
Our trial standards are, above all else, based on the ethical behavior towards the rights of those animals to which we are guardians. All trials have involved owner and veterinarian participation to ensure the greatest protection for the animals involved.
HomeoPet®’s trials are based on achieving the gold standard so treasured by evidence based medicine.
Where We Research
HomeoPet® has run trials in the Ireland and the United States and is currently running a series of clinical trials in the United Kingdom and Australia. We also run the website HPNS.org where it gathers information internationally about the efficacy of its products.
HomeoPet Research Programs
- 20 years of clinical use
- 19 years of data collection
- 2 multi-centric studies
- 1 Licensed and accredited Member of Faculty of the College of HomeoPathy
- 1 registered veterinary nurse
- 2 Professors
- 1 Double boarded behaviorist
- 1 Triple boarded behaviorist
- 2 year PhD complete research program
- 5 Universities
- 11 separate data collection periods under double blind protocols
- 5 double blinded placebo controlled trials
- 1 triple blinded, three period, three product trial
- 1 placebo controlled cross over trial
- 11,000,000 doses sold
- 15 year of registration and no reported consumer complaints
- 11 years of rigorous data collection with no adverse events reported
- Registered with the:
- FDA-CVM in the USA
- APVMA in Australia
- VMD in the UK
- NZFA in New Zealand
- All source materials are subject to strict and rigorous controls
- All materials sourced in USA and Europe
- All plant materials have full certificates of Analysis
- All non-plant materials have full certificates of pharmaceutical compliance
- Manufactured under FDA registered process
- Manufactured in an FDA inspected facility
- Stricy quality controls observed prior and post manufacturing
- 2 Deans of pharmacy involved in process